B-TEMIA announces the nomination of Mr. Neil Murdoch to Board of Directors

B-TEMIA strengthens its financial strategy and pursues the commercialization of Keeogo^TM

QUEBEC, Oct. 21, 2014 /CNW Telbec/ - B-TEMIA Inc., leader in human augmentation systems, announces the appointment of Mr. Neil Murdoch to the Board of Directors of the Company, an experienced Toronto businessman. He is an active private investor and serves on the boards of a number of private and public companies. This nomination aims at complementing the expertise of B-TEMIA's Board. Mr. Murdoch's expertise in financing and financial markets will be a valuable addition. His know-how will provide critical insights for significantly expanding B-TEMIA's business opportunities and also for speeding up the commercialization of Keeogo™.

Mr. Murdoch joined Aston Hill in August 2013 and brings a strong track record of leadership and execution in the retail investment world. Prior to joining Aston Hill, Mr. Murdoch was President & CEO of Connor, Clark & Lunn Capital Markets Inc. from 2003 to 2013, when the firm was acquired by Aston Hill and renamed Aston Hill Capital Markets Inc. Prior thereto, Mr. Murdoch was Executive Vice-President and Portfolio Manager at AIC Group of Funds. Mr. Murdoch joined AIC in 1994 when the firm managed only $150 million in assets and was instrumental in the growth of AIC to over $15 billion as one of the three principals of the business.

"I am convinced that the engagement of Mr. Murdoch as a Board member is a major turning point in the current growth stage for B-TEMIA. Mr. Murdoch's successful track record will provide the crucial guidelines to attract the right financial partners for the next commercialization phases, for the medical as well as the military market", and also for various business challenges that the team will be facing", comments Mr. Stéphane Bédard, President and CEO of B-TEMIA.

About B-TEMIA (www.b-temia.com)

B-TEMIA Inc. is a medical device manufacturer that develops and marketsproducts in the growing market of human augmentation systems. Based in Quebec City (Canada), B-TEMIA operates through two wholly-owned subsidiaries, B-TEMIA Health Inc. and B-TEMIA Military Inc. B-TEMIA owns a patent-pending wearable dermoskeleton technology that restores, maintains or enhances the mobility of users.

About Keeogo^TM (www.keeogo.com)

Keeogo™ is a motorized walking assistive device worn on the lower body that provides individuals with the leg power they need to walk more, better and keep on going throughout their day. Keeogo™ is designed for individuals who have limited walking endurance or mobility issues resulting from muscle weakness, aging in general or due to a number of medical conditions including multiple sclerosis, Parkinson's disease, knee/hip osteoarthritis or cardiovascular conditions such as peripheral artery disease.

SOURCE: B-Temia

Source: B-TEMIA Inc., 2750 Einstein Street, Québec (Québec) G1P 4R1, www.b-temia.com; Information: Stéphane Bédard, President & CEO, B-TEMIA Inc., Phone: [phone], extension 223, Cell : [phone], Email: [email protected]